Antihypertensive AgentsHypertensionDiureticsBlood PressureHydrochlorothiazideMethyldopaSodium Chloride Symporter InhibitorsAmlodipineCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsAtenololThiazidesHydralazineDoxazosinTrichlormethiazideBlood Pressure Monitoring, AmbulatoryAdrenergic beta-AntagonistsBlood Pressure DeterminationBenzothiadiazinesChlorthalidoneChemical PrecipitationLisinoprilRats, Inbred SHRIndapamideAngiotensin II Type 1 Receptor BlockersDihydropyridinesDrug Therapy, CombinationTetrazolesEnalaprilNifedipineTreatment OutcomeGuanabenzAngiotensin Receptor AntagonistsCaptoprilHypertension, RenalClonidineBenzimidazolesRisk FactorsTime FactorsToxicity TestsPatient ComplianceLosartanBendroflumethiazideDose-Response Relationship, DrugDrug PrescriptionsHypertrophy, Left VentricularMinoxidilDihydralazineSystoleDrug UtilizationNordefrinFollow-Up StudiesAdrenergic alpha-AntagonistsDouble-Blind MethodPulseProspective StudiesHeart RateReninBiphenyl CompoundsRenin-Angiotensin SystemCardiovascular DiseasesMedication AdherencePhysician's Practice PatternsClinical Trials as TopicKidneyHypertension, MalignantHypertension, RenovascularPerindoprilKidney Failure, ChronicReserpineRetrospective StudiesRats, Inbred WKYNitrendipineDrug CombinationsDrug CostsCohort StudiesTriamtereneGuanfacineBenzoatesPractice Guidelines as TopicPropranololBisoprololPrazosinValineRandomized Controlled Trials as TopicRenal Artery ObstructionToxicity Tests, AcuteAlbuminuriaDiastoleCross-Sectional StudiesDrug Utilization ReviewProteinuriaImidazolesImidazoline ReceptorsSpironolactoneRisk AssessmentAge FactorsKidney DiseasesPrevalenceCreatinine